Radiation beams target early liver tumors in korean study

NCT ID NCT07278102

Summary

This study is observing how well a radiation treatment called 90Y works for people with early-stage liver cancer. Researchers are tracking 200 patients at four Korean hospitals to see how long they live, how their tumors respond, and what side effects occur. The goal is to gather evidence about this treatment's effectiveness to help guide future medical decisions and insurance coverage.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Seoul National University Hospital

    Seoul, Seoul, 03080, South Korea

Conditions

Explore the condition pages connected to this study.